We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
Takeda Pharmaceuticals Australia has notified us that the shortage of Vyvanse 50 mg capsules has resolved, and that due to manufacturing issues the shortage of Vyvanse 30 mg has been extended until 31 March 2024.
The most up-to-date information about these shortages is published on the Medicine Shortage Reports Database.
Important information for patients, carers, pharmacists and prescribers is available at About the shortage of Vyvanse (lisdexamfetamine dimesilate) capsules.